Journey Medical (DERM) Stock Chart & Stock Price History → Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (From Behind the Markets) (Ad) Free DERM Stock Alerts $3.48 +0.04 (+1.16%) (As of 10:23 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Journey Medical Stock Price Performance5 Day Performance-5.69%1 Month Performance-15.33%3 Month Performance-26.74% Receive DERM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Journey Medical and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsThe Weight Loss Pill That Could Disrupt a $32 Billion IndustryA revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.Don't miss out on the "next Ozempic" >>> DERM Stock Chart for Wednesday, May, 8, 2024 DERM Chart by TradingView Journey Medical Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$3.55$3.44-3.10%$3.60$3.3584,124 shs$68.56 million05/06/2024$3.69$3.55-3.79%$3.74$3.5151,257 shs$70.75 million05/03/2024$3.63$3.69+1.65%$3.73$3.5251,784 shs$73.54 million05/02/2024$3.51$3.63+3.42%$3.64$3.4047,928 shs$72.35 million05/01/2024$3.69$3.51-4.88%$3.70$3.3762,457 shs$69.95 million04/30/2024$3.33$3.69+10.81%$3.72$3.3498,295 shs$73.54 million Get the Latest News and Ratings for DERM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Journey Medical and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$3.40$3.33-2.06%$3.55$3.27141,312 shs$66.37 million04/26/2024$3.50$3.40-2.86%$3.54$3.3664,845 shs$67.76 million04/25/2024$3.40$3.50+2.94%$3.57$3.3546,084 shs$69.76 million04/24/2024$3.54$3.40-3.95%$3.57$3.3160,469 shs$67.76 million04/23/2024$3.54$3.54$3.59$3.4575,358 shs$70.55 million04/22/2024$3.48$3.54+1.72%$3.60$3.4437,549 shs$70.55 million04/19/2024$3.58$3.48-2.79%$3.64$3.40101,338 shs$69.36 million04/18/2024$3.86$3.58-7.25%$3.86$3.51189,097 shs$71.35 million04/17/2024$3.80$3.86+1.58%$3.90$3.62129,238 shs$76.93 million04/16/2024$4.02$3.80-5.47%$4.00$3.70118,552 shs$75.73 million04/15/2024$4.42$4.02-9.05%$4.39$4.00135,914 shs$80.13 million04/12/2024$4.31$4.42+2.55%$4.64$4.28138,724 shs$88.09 million04/11/2024$4.38$4.31-1.60%$4.55$3.90295,717 shs$85.91 million04/10/2024$4.00$4.38+9.50%$4.40$3.88245,006 shs$87.29 million04/09/2024$4.11$4.00-2.68%$4.18$3.86106,729 shs$79.72 million04/08/2024$3.68$4.11+11.68%$4.35$3.60272,430 shs$81.91 million04/05/2024$4.36$3.68-15.60%$4.32$3.61313,017 shs$68.12 million04/04/2024$3.42$4.36+27.49%$4.57$3.30683,451 shs$80.70 million04/03/2024$3.40$3.42+0.59%$3.48$3.3463,542 shs$63.30 million04/02/2024$3.31$3.40+2.72%$3.44$3.2057,534 shs$62.93 million04/01/2024$3.68$3.31-10.05%$3.55$3.23291,713 shs$61.26 million03/29/2024$3.68$3.68$3.99$3.6599,042 shs$68.12 million03/28/2024$3.89$3.68-5.40%$3.99$3.6699,036 shs$68.12 million03/27/2024$3.69$3.89+5.42%$3.98$3.60122,669 shs$72.00 million03/26/2024$2.92$3.69+26.37%$4.18$3.23637,680 shs$68.30 million03/25/2024$3.30$2.92-11.52%$3.27$2.85413,320 shs$54.05 million03/22/2024$3.82$3.30-13.61%$3.56$3.05373,373 shs$61.08 million03/21/2024$3.84$3.82-0.52%$4.30$3.76250,708 shs$70.71 million03/20/2024$3.79$3.84+1.32%$3.92$3.6762,094 shs$71.08 million03/19/2024$3.74$3.79+1.34%$3.90$3.52158,312 shs$70.15 million03/18/2024$3.40$3.74+10.00%$3.97$3.38210,449 shs$69.23 million03/15/2024$3.47$3.40-2.02%$3.62$3.29106,298 shs$62.93 million03/14/2024$3.41$3.47+1.76%$3.48$3.31124,463 shs$64.23 million03/13/2024$3.48$3.41-2.01%$3.70$3.3853,218 shs$63.12 millionThe Weight Loss Pill That Could Disrupt a $32 Billion Industry (Ad)A revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.Don't miss out on the "next Ozempic" >>>03/12/2024$3.37$3.48+3.26%$3.50$3.3198,028 shs$64.42 million03/11/2024$3.45$3.37-2.32%$3.43$3.22158,889 shs$62.38 million03/08/2024$3.47$3.45-0.58%$3.60$3.3358,772 shs$63.86 million03/07/2024$3.49$3.47-0.57%$3.62$3.3759,215 shs$64.23 million03/06/2024$3.73$3.49-6.43%$3.74$3.40128,984 shs$64.60 million03/05/2024$4.00$3.73-6.75%$4.05$3.7083,574 shs$69.04 million03/04/2024$4.13$4.00-3.15%$4.30$3.94162,952 shs$74.04 million03/01/2024$3.95$4.13+4.56%$4.14$3.8683,410 shs$76.45 million02/29/2024$3.65$3.95+8.22%$3.98$3.65102,907 shs$73.11 million02/28/2024$4.06$3.65-10.10%$4.12$3.45192,675 shs$67.56 million02/27/2024$3.77$4.06+7.69%$4.12$3.8279,780 shs$75.15 million02/26/2024$3.65$3.77+3.29%$3.88$3.44130,189 shs$69.78 million02/23/2024$3.75$3.65-2.67%$3.80$3.6292,048 shs$67.56 million02/22/2024$3.76$3.75-0.27%$3.89$3.6361,876 shs$69.41 million02/21/2024$3.73$3.76+0.80%$3.92$3.6655,846 shs$69.60 million02/20/2024$4.26$3.73-12.44%$4.20$3.62368,899 shs$69.04 million02/19/2024$4.26$4.26$4.46$4.20100,500 shs$78.85 million02/16/2024$4.40$4.26-3.18%$4.46$4.20100,227 shs$78.85 million02/15/2024$4.46$4.40-1.35%$4.59$4.32191,007 shs$81.44 million02/14/2024$4.50$4.46-0.89%$4.67$4.4285,161 shs$82.56 million02/13/2024$4.95$4.50-9.09%$4.94$4.4570,923 shs$83.30 million02/12/2024$4.97$4.95-0.40%$5.04$4.78129,383 shs$91.62 million02/09/2024$4.75$4.97+4.63%$5.01$4.67120,041 shs$92.00 million02/08/2024$4.57$4.75+3.94%$4.83$4.5556,084 shs$87.92 million02/07/2024$4.37$4.57+4.58%$4.69$4.37157,206 shs$84.59 million Related Companies: Assembly Biosciences Stock Chart vTv Therapeutics Stock Chart Landos Biopharma Stock Chart Rallybio Stock Chart YS Biopharma Stock Chart MediciNova Stock Chart SCYNEXIS Stock Chart SELLAS Life Sciences Group Stock Chart Viveon Health Acquisition Stock Chart Carisma Therapeutics Stock Chart Receive DERM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Journey Medical and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DERM) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward PressAI “wealth window” is closing June 25thParadigm PressClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Journey Medical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.